Dr. Olivier answers the question: 'Topical Prostaglandins For Glaucoma?' Aug. 24, 2009— -- Question: What are topical prostaglandins, when are they used to treat glaucoma, and what are the ...

Please provide your email address to receive an email when new articles are posted on . Data derived from Chauhan MZ, et al. Ophthalmol Glaucoma. 2025;doi:10.1016/j ...

Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...

Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma. Neil Minkoff, MD: One of the things that I’m trying to get my arms around here is that we’ve been ...

A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced. Neil Minkoff, MD: And just to help make sure that we’re all at least on a level playing ...

Please provide your email address to receive an email when new articles are posted on . A study looked at the time interval for IOP follow-up after initiation of prostaglandin analog therapy.

WASHINGTON (Reuters) - For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global ...

Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.